BLOOMFIELD, N.J.--(BUSINESS WIRE)--Alfacell Corporation (NASDAQ: ACEL), a biopharmaceutical company focused on the discovery, development and commercialization of novel ribonuclease (RNase) therapeutics for cancer and other life-threatening diseases, today announced that Dr. Susanna Rybak, a member of Alfacell’s Scientific Advisory Board, is an invited speaker at IBC Life Sciences’ 17th Annual Conference on Antibody Engineering and Immunotherapeutics for the 21st Century, to be held December 10-14, 2006 in San Diego, CA.
